Akèy › Ensifizans renn
Etid klinik pou Ensifizans renn ap rekrite nan Etazini
50 etid pou Ensifizans renn ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Boston, MA14 etid
- Houston, TX13 etid
- Dallas, TX9 etid
- New York City, NY7 etid
- Chicago, IL7 etid
- Queens, NY6 etid
- Atlanta, GA5 etid
- Durham, NC5 etid
- Baltimore, MD5 etid
- Phoenix, AZ5 etid
- Orlando, FL5 etid
- Mountain View, CA4 etid
- Jacksonville, FL4 etid
- Los Angeles, CA4 etid
- Memphis, TN4 etid
- Raleigh, NC4 etid
- Charlotte, NC4 etid
- Greenville, SC4 etid
- San Francisco, CA3 etid
- St. Louis, MO3 etid
- Philadelphia, PA3 etid
- Lexington, KY3 etid
- Tucson, AZ3 etid
- Columbia, SC3 etid
- Rochester, MN3 etid
- Spartanburg, SC3 etid
- Victorville, CA3 etid
- Kansas City, MO3 etid
- Long Beach, CA3 etid
- Sarasota, FL3 etid
- Seattle, WA3 etid
- Pomona, CA3 etid
- Norfolk, VA3 etid
- Riverside, CA3 etid
- Santa Clarita, CA3 etid
- Santa Monica, CA3 etid
- Chattanooga, TN3 etid
- Tampa, FL3 etid
- The Bronx, NY3 etid
- Albuquerque, NM3 etid
Pa eta
- Alabama5 etid
- Arizona5 etid
- Colorado4 etid
- Florid14 etid
- Georgia9 etid
- Illinois7 etid
- Indiana4 etid
- Iowa3 etid
- Kalifòni19 etid
- Kentucky5 etid
- Maryland5 etid
- Massachusetts16 etid
- Michigan4 etid
- Minnesota5 etid
- Mississippi4 etid
- Missouri6 etid
- Nebraska3 etid
- New Jersey5 etid
- New Mexico4 etid
- New York15 etid
- North Carolina10 etid
- Ohio4 etid
- Pennsylvania7 etid
- South Carolina8 etid
- Tennessee7 etid
- Texas15 etid
- Virginia6 etid
- Washington3 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05485961Decellularized Femoral Artery Allograft (Nexeon AVX) Prospective Registry
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT05880537Partners Calciphylaxis Biobank
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT03032835Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT05287945Study to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patients With ESRD
Ap rekriteFaz 1/2
Laj 40 a 70 · Tout sèks · Mizajou Sep 9, 2026 · NCT07224763Pivotal Study of the Velocity™ pAVF System
Ap rekrite
Laj 18 a 80 · Tout sèks · Mizajou Sep 2, 2026 · NCT07153939Duke APOL1 Research Biorepository
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Aug 27, 2026 · NCT04160507Incremental Hemodialysis for Veterans in the First Year of Dialysis (IncHVets)
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT05465044A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
Ap rekriteFaz 1/2Volontè an sante akeyi
Laj 18 a 55 · Tout sèks · Mizajou Aug 14, 2026 · NCT06749457Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 10, 2026 · NCT04634916Incremental Hemodialysis: The TwoPlus Trial
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 6, 2026 · NCT05828823Staged Kidney Transplantation During Combined Heart/Kidney Transplantation
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 24, 2026 · NCT06877169Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 20, 2026 · NCT04163614CAPABLE Transplant
Ap rekrite
Laj 18 a 99 · Tout sèks · Mizajou Jul 20, 2026 · NCT06326905Post Market Study for VasQ, an External Support Implant for Arteriovenous Fistula
Ap rekrite
Laj 18 a 80 · Tout sèks · Mizajou Jul 14, 2026 · NCT06516653Virtual Reality in End Stage Kidney Disease
Ap rekrite
Tout laj · Tout sèks · Mizajou Jul 10, 2026 · NCT06356168AMSC for Reducing Anastomotic Stenosis in Primary Arteriovenous Anastomoses
Ap rekriteFaz 1
Laj 18 a 85 · Tout sèks · Mizajou Jul 10, 2026 · NCT04392206Moda-flx Hemodialysis System™ Under Professional Care Settings by Trained Individuals and At Home by Participants
Ap rekrite
Laj 18 a 80 · Tout sèks · Mizajou Jul 6, 2026 · NCT06613568Effect of the Amplifi™ Vein Dilation System on Outflow Vein Dilation and AV Fistula Maturation (AMPLIFI-1)
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 23, 2026 · NCT07211035A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Severe Renal Impairment or End Stage Renal Disease
Ap rekriteFaz 1
Laj 18 a 85 · Tout sèks · Mizajou Jun 16, 2026 · NCT07559396Preoperative Hemodialysis Timing in Patients With End-Stage Kidney Disease: The POD-ESKD Pilot Trial
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 11, 2026 · NCT07339202PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jun 1, 2026 · NCT06422871RaDIANT Health Systems Intervention
Ap rekriteVolontè an sante akeyi
Laj 18 a 80 · Tout sèks · Mizajou May 26, 2026 · NCT07033117Kidney Transplant Improvement Through New Exercise Training to Increase Capacity
Ap rekrite
Laj 60 ak plis · Tout sèks · Mizajou May 6, 2026 · NCT07446296International (Pediatric) Peritoneal Biobank
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
1 Day – 90 Years · Tout sèks · Mizajou Apr 30, 2026 · NCT01893710Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.